93 related articles for article (PubMed ID: 6672016)
1. Determination of lodoxamide in plasma using ion-pairing and reversed-phase high-performance liquid chromatography.
Honigberg IL; Stewart JT; Ewing BJ; Taylor WD
J Chromatogr; 1983 Aug; 276(1):213-7. PubMed ID: 6672016
[No Abstract] [Full Text] [Related]
2. Analysis of the variance components in a pharmaceutical aerosol product: lodoxamide tromethamine.
Havel HA; Beaubien LJ; Haaland PD
J Pharm Sci; 1985 Sep; 74(9):978-82. PubMed ID: 4067853
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of lodoxamide and verapamil on antimicrobial action in vitro.
McGregor JA; Levin MJ; Masters H
J Infect Dis; 1986 Sep; 154(3):542-3. PubMed ID: 3734496
[No Abstract] [Full Text] [Related]
4. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
Grutzmacher RD; Foster RS; Feiler LS
Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
[TBL] [Abstract][Full Text] [Related]
5. Effects of lodoxamide tromethamine on paraplegia that occurs after infrarenal aortic occlusion in the rabbit.
Ball TD; Lundy EF; Zelenock GB; D'Alecy LG
J Vasc Surg; 1987 Dec; 6(6):572-7. PubMed ID: 3694755
[TBL] [Abstract][Full Text] [Related]
6. Protective effect opf lodoxamide tromethamine on allergen inhalation challenge.
Watt GD; Bui TC; Bewtra AK; Townley RG
J Allergy Clin Immunol; 1980 Oct; 66(4):286-94. PubMed ID: 7419830
[TBL] [Abstract][Full Text] [Related]
7. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
Mann JS; Clement P; Sheridan AQ; Soryal I; Fairfax AJ; Holgate ST
J Allergy Clin Immunol; 1985 Jul; 76(1):83-90. PubMed ID: 4008815
[TBL] [Abstract][Full Text] [Related]
8. Lodoxamide tromethamine prevents neutrophil accumulation in reexpansion pulmonary edema.
Veal CF; Jackson RM; Brannen AL; Fulmer JD
J Cardiovasc Pharmacol; 1989 Aug; 14(2):227-32. PubMed ID: 2476595
[TBL] [Abstract][Full Text] [Related]
9. Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine.
Parenteau GL; Clark RE
Ann Thorac Surg; 1991 Oct; 52(4):832-8. PubMed ID: 1929638
[TBL] [Abstract][Full Text] [Related]
10. Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine.
Parrish RW; Davies BH
Thorax; 1983 Jun; 38(6):458-62. PubMed ID: 6136101
[TBL] [Abstract][Full Text] [Related]
11. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm.
Ungerer RG; Tashkin DP; Siegel SC; Deutsch RI
J Allergy Clin Immunol; 1981 Dec; 68(6):471-8. PubMed ID: 7310012
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of oxidative enzymes by anti-allergy drugs.
White GJ
Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
[TBL] [Abstract][Full Text] [Related]
13. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
Reilly FD; Dimlich RV
Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
[TBL] [Abstract][Full Text] [Related]
14. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
Reilly FD; Cilento EV; McCuskey RS
Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
[TBL] [Abstract][Full Text] [Related]
15. Effect of lodoxamide on the secretory response induced by Escherichia coli and Vibrio cholerae enterotoxins in infant mice.
Knoop FC; Thomas DD
Infect Immun; 1984 May; 44(2):406-8. PubMed ID: 6143729
[TBL] [Abstract][Full Text] [Related]
16. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
Reilly FD; Dimlich RV
Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
[TBL] [Abstract][Full Text] [Related]
17. Effects of lodoxamide on ischemic reperfused myocardium.
Jolly SR; Abrams GD; Romson JL; Bailie MB; Lucchesi BR
J Cardiovasc Pharmacol; 1982; 4(3):441-8. PubMed ID: 6177941
[TBL] [Abstract][Full Text] [Related]
18. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury.
Barr ML; Carey JN; Nishanian GP; Roberts RF; Sakamaki Y; Darbinian SH; Starnes VA
J Thorac Cardiovasc Surg; 1998 Mar; 115(3):631-6; discussion 636-7. PubMed ID: 9535451
[TBL] [Abstract][Full Text] [Related]
19. The effect of lodoxamide tromethamine on the immediate asthmatic response to allergen provocation.
Ollier S; Graham VA; Bentley S; Davies RJ
Clin Allergy; 1982 Nov; 12(6):587-94. PubMed ID: 7151268
[TBL] [Abstract][Full Text] [Related]
20. The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.
Johnson HG; Sheridan AQ
Agents Actions; 1986 Jun; 18(3-4):301-5. PubMed ID: 2875630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]